Emmerik F A Leijten

Plasma metabolomics reveals candidate biomarkers associated with individual treatment response in psoriatic arthritis

Psoriatic arthritis (PsA) is a clinically heterogeneous inflammatory disease for which optimal treatment selection remains unclear. Robust biomarkers that predict treatment response and identify patient-specific factors to inform treatment choice could advance precision medicine...